Back to search

Article

PD-1 Blockade-activated Neoantigen Specific Cellular Therapy For Advanced Relapsed Non Small Cell Lung Cancer

2024-10-21

Abstract excerpt

<title>Abstract</title> <p>Background Due to its strong immunogenicity and tumor specificity, neoplastic antigen has emerged as an immunotherapy target with wide therapeutic prospect and clinical application value. Anti-programmed death-1 (PD-1) antibodies reinvigorate T cell-mediated antitumor immunity .So we conducted single-arm trial to assess the safety and efficacy of PD-1 blockade(Camrelizumab)-activated N...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fa8ff7d8-353d-5fea-8402-8d7cedccad30
DOI
10.21203/rs.3.rs-5024390/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PD-1 Blockade-activated Neoantigen Specific Cellular Therapy For Advanced Relapsed Non Small Cell Lung CancerDOI 10.21203/rs.3.rs-5024390/v1
Select a neighboring publication to make it the new centre.